Acerus Pharmaceuticals Overview
- Year Founded
-
2008
- Status
-
Private
- Employees
-
11
- Latest Deal Type
-
PIPE
- Financing Rounds
-
10
- Investments
-
2
Acerus Pharmaceuticals General Information
Description
Acerus Pharmaceuticals Corp is a specialty pharmaceutical company focused on the development, manufacture, marketing and distribution of branded products that improve patient experience, with a primary focus on the field of men's health. Its foundational product includes NATESTO, a testosterone therapy based on nasal gel technology. The company commercializes its products via its salesforce in the United States and Canada, and through a global network of licensed distributors in other territories.
Contact Information
Website
www.aceruspharma.comCorporate Office
- 7025 Langer Drive
- Suite 205
- Mississauga, Ontario L5N 0E8
- Canada
Corporate Office
- 7025 Langer Drive
- Suite 205
- Mississauga, Ontario L5N 0E8
- Canada
Acerus Pharmaceuticals Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Acerus Pharmaceuticals Comparisons
Industry
Financing
Details
Acerus Pharmaceuticals Competitors (21)
One of Acerus Pharmaceuticals’s 21 competitors is Durect, a Formerly VC-backed company based in Cupertino, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Durect | Formerly VC-backed | Cupertino, CA | ||||
| Novartis | Corporation | Basel, Switzerland | ||||
| Endoceutics | Private Equity-Backed | Quebec City, Canada | ||||
| Noven Pharmaceuticals | Corporate Backed or Acquired | Miami, FL | ||||
| Cipher Pharmaceuticals | Formerly PE-Backed | Mississauga, Canada |
Acerus Pharmaceuticals Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Acerus Pharmaceuticals Patents
Acerus Pharmaceuticals Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-3893885-A4 | Active ester derivatives of testosterone, compositions and uses thereof | Inactive | 14-Dec-2018 | ||
| EP-3893885-A1 | Active ester derivatives of testosterone, compositions and uses thereof | Inactive | 14-Dec-2018 | ||
| US-20200188412-A1 | Active ester derivatives of testosterone, compositions and uses thereof | Inactive | 14-Dec-2018 | ||
| AU-2019396139-A1 | Active ester derivatives of testosterone, compositions and uses thereof | Pending | 14-Dec-2018 | ||
| CA-3123301-A1 | Nasal pharmaceutical testosterone ester gel compositions for nasal administration and method | Pending | 14-Dec-2018 | A61K9/0043 |
Acerus Pharmaceuticals Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Acerus Pharmaceuticals Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Acerus Pharmaceuticals Acquisitions (2)
Acerus Pharmaceuticals’s most recent deal was a Merger/Acquisition with Serenity Pharmaceuticals for . The deal was made on 07-Mar-2022.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Serenity Pharmaceuticals | 07-Mar-2022 | Merger/Acquisition | Pharmaceuticals | ||
| J5 Acquisition | 14-Jul-2011 | Merger/Acquisition | Special Purpose Acquisition Company (SPAC) |
Acerus Pharmaceuticals FAQs
-
When was Acerus Pharmaceuticals founded?
Acerus Pharmaceuticals was founded in 2008.
-
Where is Acerus Pharmaceuticals headquartered?
Acerus Pharmaceuticals is headquartered in Mississauga, Canada.
-
What is the size of Acerus Pharmaceuticals?
Acerus Pharmaceuticals has 11 total employees.
-
What industry is Acerus Pharmaceuticals in?
Acerus Pharmaceuticals’s primary industry is Pharmaceuticals.
-
Is Acerus Pharmaceuticals a private or public company?
Acerus Pharmaceuticals is a Private company.
-
What is Acerus Pharmaceuticals’s current revenue?
The current revenue for Acerus Pharmaceuticals is .
-
How much funding has Acerus Pharmaceuticals raised over time?
Acerus Pharmaceuticals has raised $86.4M.
-
Who are Acerus Pharmaceuticals’s investors?
Research Capital, First Generation Capital, and J5 Acquisition have invested in Acerus Pharmaceuticals.
-
Who are Acerus Pharmaceuticals’s competitors?
Durect, Novartis, Endoceutics, Noven Pharmaceuticals, and Cipher Pharmaceuticals are some of the 21 competitors of Acerus Pharmaceuticals.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
